دورية أكاديمية
أعرض في EDS

Full-body skin examination in screening for cutaneous malignancy: a focus on concealed sites and the practices of Australian dermatologists.

التفاصيل البيبلوغرافية
العنوان: Full-body skin examination in screening for cutaneous malignancy: a focus on concealed sites and the practices of Australian dermatologists.
المؤلفون: Pham JP; St Vincent's Hospital Sydney, Darlinghurst, NSW, Australia.; School of Clinical Medicine, UNSW Medicine and Health, Darlinghurst, NSW, Australia., Allen N; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Star P; St Vincent's Hospital Sydney, Darlinghurst, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Melanoma Institute of Australia, North Sydney, NSW, Australia., Cust AE; The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Sydney, Australia., Stewart C; Sydney Health Law, Sydney Law School, University of Sydney, Sydney, NSW, Australia., Guitera P; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Melanoma Institute of Australia, North Sydney, NSW, Australia., Marghoob AA; Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, United States., Smith A; St Vincent's Hospital Sydney, Darlinghurst, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Melanoma Institute of Australia, North Sydney, NSW, Australia.
المصدر: International journal of dermatology [Int J Dermatol] 2024 Apr; Vol. 63 (4), pp. 467-473. Date of Electronic Publication: 2023 Nov 30.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Blackwell Science Country of Publication: England NLM ID: 0243704 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-4632 (Electronic) Linking ISSN: 00119059 NLM ISO Abbreviation: Int J Dermatol Subsets: MEDLINE
أسماء مطبوعة: Publication: Oxford : Blackwell Science
Original Publication: Philadelphia, Lippincott.
مواضيع طبية MeSH: Dermatologists* , Skin Neoplasms*/pathology, Humans ; Cross-Sectional Studies ; Australia ; Surveys and Questionnaires
مستخلص: Background: Full-body skin examination (FSE) is a vital practice in the diagnosis of cutaneous malignancy. Precisely how FSE should be conducted with respect to concealed site inclusion remains poorly elucidated.
Objective: To establish the approach of Australian dermatologists to concealed site examination (CSE).
Methods: A cross-sectional study was performed consisting of an online self-administered 11-question survey delivered to fellows of the Australasian College of Dermatologists.
Results: There were 237 respondents. Anogenitalia was the least often examined concealed site (4.6%), and 59.9, 32.9, and 14.3% reported always examining the scalp, breasts, and oral mucosa, respectively. Patient concern was the most frequently cited factor prompting examination, while many cited low incidence of pathology and limited chaperone availability as the main barriers to routine examination of these sites.
Conclusion: Most Australian dermatologists do not routinely examine breasts, oral mucosal, or anogenital sites as part of an FSE. Emphasis should be made on identifying individual patient risk factors and education regarding self-examination of sensitive sites. A consensus approach to the conduct of the FSE, including concealed sites, is needed to better delineate clinician responsibilities and address medicolegal implications.
(© 2023 The Authors. International Journal of Dermatology published by Wiley Periodicals LLC on behalf of the International Society of Dermatology.)
References: Arch Dermatol. 2008 Apr;144(4):515-21. (PMID: 18427046)
J Am Acad Dermatol. 2017 Mar;76(3):494-498.e2. (PMID: 28413056)
J Low Genit Tract Dis. 2020 Jul;24(3):272-276. (PMID: 32205765)
J Am Acad Dermatol. 2014 Dec;71(6):1241-9. (PMID: 25267379)
Cancer Surv. 1994;19-20:219-40. (PMID: 7534627)
Jpn J Clin Oncol. 2005 Apr;35(4):202-6. (PMID: 15845569)
J Natl Cancer Inst. 1996 Jan 3;88(1):17-23. (PMID: 8847720)
Arch Dermatol. 2004 May;140(5):530-4. (PMID: 15148096)
Sex Health. 2007 Jun;4(2):89-93. (PMID: 17524285)
Aust Fam Physician. 2017 Nov;46(11):867-873. (PMID: 29101925)
Dermatol Pract Concept. 2019 Apr 30;9(2):132-138. (PMID: 31106016)
JAMA. 2016 Jul 26;316(4):429-35. (PMID: 27458948)
Med J Aust. 2011 Mar 7;194(5):253-5. (PMID: 21382000)
Clin Dermatol. 2012 Mar-Apr;30(2):174-80. (PMID: 22330660)
Ann Surg Oncol. 2014 Nov;21(12):3985-91. (PMID: 24912613)
Int J Cancer. 2010 Jan 15;126(2):450-8. (PMID: 19609948)
Transpl Int. 2010 Feb;23(2):191-9. (PMID: 19793075)
Int J Dermatol. 2007 Jun;46(6):575-7. (PMID: 17550554)
Gynecol Oncol. 2018 Jul;150(1):180-189. (PMID: 29728261)
Ophthalmology. 2012 Aug;119(8):1582-9. (PMID: 22503229)
JAMA Dermatol. 2016 Sep 1;152(9):1052-4. (PMID: 27166873)
Cancer. 2001 Apr 15;91(8):1520-4. (PMID: 11301400)
Cutis. 2021 Feb;107(2):E29-E32. (PMID: 33891852)
J Am Acad Dermatol. 2002 May;46(5):710-4. (PMID: 12004312)
J Clin Oncol. 2017 Jan;35(1):63-71. (PMID: 28034073)
CA Cancer J Clin. 2018 Nov;68(6):394-424. (PMID: 30207593)
Arch Dermatol. 2009 Aug;145(8):873-6. (PMID: 19687416)
Dermatol Online J. 2017 Mar 15;23(3):. (PMID: 28329513)
معلومات مُعتمدة: P30 CA008748 United States CA NCI NIH HHS; 2008454 National Health and Medical Research Council (NHMRC)
تواريخ الأحداث: Date Created: 20231130 Date Completed: 20240322 Latest Revision: 20240816
رمز التحديث: 20240816
مُعرف محوري في PubMed: PMC11326497
DOI: 10.1111/ijd.16942
PMID: 38036942
قاعدة البيانات: MEDLINE
الوصف
تدمد:1365-4632
DOI:10.1111/ijd.16942